When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RLMD - Relmada Therapeutics GAAP EPS of -$0.84 beats by $0.06
Relmada Therapeutics Inc.
2023-08-08 16:44:44 ET
Relmada Therapeutics press release ( NASDAQ: RLMD ): Q2 GAAP EPS of -$0.84 beats by $0.06 .
As of June 30, 2023, the Company had cash, cash equivalents, and short-term investments of approximately $118.5 million, compared to cash, cash equivalents, and short-term investments of approximately $148.3 million at December 31, 2022.